drugset / Trial / NCT01227876

Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery

NCT01227876 ↗

Phase 3 Completed 106 enrolled Azidus Brasil
RandomizedParallel-groupSingle-blindTreatment

Summary

Is the primary objective of this investigation to compare the clinical efficacy of the drug test - Ster ® (prednisolone 1% ophthalmic suspension - Union Chemicals) in the comparator - Fort ® Pred (prednisolone 1% ophthalmic suspension - Allergan) in the control of postoperative inflammation in cataract surgery by phacoemulsification through periodic measurement of efficiency scores (number of cells in the anterior chamber, the presence of fibrin in the anterior chamber, conjunctival hyperemia, corneal edema and Descemet folds).

Timeline

Start
2011-01
Primary completion
2011-02
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified 1 % Other

Indications